Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2026-02-06 @ 12:00 AM
Study NCT ID:
NCT06848920
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-02-27
First Post:
2025-01-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Sinibolimab Combined with Lenvatinib As Neoadjuvant Therapy for Locally Advanced Unresectable Differentiated Thyroid Carcinoma
Sponsor:
Organization: